The need for speed? Exploring the risks and benefits of pharmacological treatment for adult ADHD in prisons

References

• Advokat, C., & Scheithauer, M. (2013). Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers. Frontiers in Neuroscience, 82(7), 1–9. https://doi.org/10.3389/fnins.2013.00082
   Google Scholar
• American Psychiatric Association (APA). (1987). Diagnostic and statistical manual of mental disorders (DSM-III-R) (3rd ed. rev.). APA.
   Google Scholar
• American Psychiatric Association (APA). (2022). Diagnostic and statistical manual of mental disorders (DSM-5-TR) (5th ed. text rev.). APA.
   Google Scholar
• American Psychological Association. (2009). ICD vs. DSM. Monitor on Psychology, 40(9), 63. https://www.apa.org/monitor/2009/10/icd-dsm
   Google Scholar
• Appelbaum, K. L. (2009). Attention deficit hyperactivity disorder in prison: A treatment protocol. The Journal of the American Academy of Psychiatry and the Law, 37(1), 45–49. https://jaapl.org/content/37/1/45
   PubMed Web of Science ®Google Scholar
• Appelbaum, K. L. (2011). Stimulant use under a prison treatment protocol for attention-deficit/hyperactivity disorder. Journal of Correctional Health Care, 17(3), 218–225. https://doi.org/10.1177/1078345811401356
   PubMedGoogle Scholar
• Asherson, P., Evans, C., & Young, S. (2016). A pilot study of Concerta XL in adult offenders with ADHD (CIAO-I). King’s College London. https://kclpure.kcl.ac.uk/portal/en/publications/a-pilot-study-of-concerta-xl-in-adult-offenders-with-adhd(68d820ff-1026-4cdc-867e-4fa0325d162c).html
   Google Scholar
• Asherson, P., Johansson, L., Holland, R., Bedding, M., Forrester, A., Giannulli, L., Ginsberg, Y., Howitt, S., Kretzschmar, I., Lawrie, S. M., Marsh, C., Kelly, C., Mansfield, M., McCafferty, C., Khan, K., Müller-Sedgwick, U., Strang, J., Williamson, G., Wilson, L., … Thomson, L. D. G. (2023). Randomised controlled trial of the short-term effects of osmotic-release oral system methylphenidate on symptoms and behavioural outcomes in young male prisoners with attention deficit hyperactivity disorder: CIAO-II study. British Journal of Psychiatry: The Journal of Mental Science, 222(1), 7–17. https://doi.org/10.1192/bjp.2022.77
   PubMed Web of Science ®Google Scholar
• Asherson, P., Johansson, L., Holland, R., Fahy, T., Forester, A., Howitt, S., Lawrie, S., Strang, J., Young, S., Landau, S., & Thomson, L. (2019). Randomised controlled trial of the short-term effects of OROS-methylphenidate on ADHD symptoms and behavioural outcomes in young male prisoners with attention-deficit/hyperactivity disorder (CIAO-II). Trials, 20(1), 663. https://doi.org/10.1186/s13063-019-3705-9
   PubMed Web of Science ®Google Scholar
• Australian ADHD Guideline Development Group (AAGDG). (2022). Australian evidence-based clinical practice guideline for attention deficit hyperactivity disorder (ADHD). Australian ADHD Professionals Association.
   Google Scholar
• Australian Institute of Health and Welfare (AIHW). (2019). The health of Australia’s prisoners, 2018 (Cat. No. PHE 246). AIHW.
   Google Scholar
• Baggio, S., Heller, P., Perroud, N., Buadze, A., Schleifer, R., Wolff, H., Liebrenz, M., & Gétaz, L. (2022). Attention deficit hyperactivity disorder as a neglected psychiatric disease in prison: Call for identification and treatment. Forensic Science International: Mind and Law, 3, 100071. https://doi.org/10.1016/j.fsiml.2022.100071
   Google Scholar
• Barkley, R. (2002). International consensus statement on ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 41(12), 1389. https://doi.org/10.1097/00004583-200212000-00001
   PubMed Web of Science ®Google Scholar
• Bastiaens, L., Scott, O., & Galus, J. (2019). Treatment of adult ADHD without stimulants: Effectiveness in a dually diagnosed correctional population. Psychiatric Quarterly, 90(1), 41–46. https://doi.org/10.1007/s11126-018-9602-7
   PubMed Web of Science ®Google Scholar
• Biederman, J., Monuteaux, M. C., Spencer, T., Wilens, T. E., MacPherson, H. A., & Faraone, S. V. (2008). Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: A naturalistic controlled 10-year follow-up study. The American Journal of Psychiatry, 165(5), 597–603. https://doi.org/10.1176/appi.ajp.2007.07091486
   PubMed Web of Science ®Google Scholar
• Boesen, K., Paludan-Müller, A., Gøtzsche, P., & Jørgensen, K. (2022). Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database of Systematic Reviews, 2022(2), 1–192. https://doi.org/10.1002/14651858.CD012857.pub2
   Google Scholar
• Bruchmüller, K., Margraf, J., & Schneider, S. (2012). Is ADHD diagnosed in accord with diagnostic criteria? Overdiagnosis and influence of client gender on diagnosis. Journal of Consulting and Clinical Psychology, 80(1), 128–138. https://doi.org/10.1037/a0026582
   PubMed Web of Science ®Google Scholar
• Chang, Z., Lichtenstein, P., Långström, N., Larsson, H., & Fazel, S. (2016). Association between prescription of major psychotropic medications and violent reoffending after prison release. JAMA, 316(17), 1798–1807. https://doi.org/10.1001/jama.2016.15380
   PubMed Web of Science ®Google Scholar
• Conrad, P. (1975). The discovery of hyperkinesis: Notes on the medicalization of deviant behavior. Social Problems, 23(1), 12–21. https://doi.org/10.2307/799624
   PubMed Web of Science ®Google Scholar
• Conrad, P., & Bergey, M. (2014). The impending globalization of ADHD: Notes on the expansion and growth of a medicalized disorder. Social Science & Medicine, 122, 31–43. https://doi.org/10.1016/j.socscimed.2014.10.019
   PubMed Web of Science ®Google Scholar
• Conrad, P., & Potter, D. (2000). From hyperactive children to ADHD adults: Observations on the expansion of medical categories. Social Problems, 47(4), 559–582. https://doi.org/10.2307/3097135
   Web of Science ®Google Scholar
• Corrective Services Administrators’ Council. (2018). Guiding principles for corrections in Australia Corrective Services Administrators’ Council. https://files.corrections.vic.gov.au/2021-06/guiding_principles_correctionsaustrevised2018.pdf
   Google Scholar
• Cunial, K., Casey, L., Bell, C., & Kebbell, M. (2019). Police perceptions of the impact that ADHD has on conducting cognitive interviews with youth. Psychiatry, Psychology and Law, 26(2), 252–273. https://doi.org/10.1080/13218719.2018.1504241
   PubMedGoogle Scholar
• Dagistan, A., Gica, S., Aydin, A., & Cilli, A. (2022). Prevalence of probable attention‐deficit/hyperactivity disorder in inmates and its relationship with recidivism. Journal of Forensic Sciences, 67(1), 289–296. https://doi.org/10.1111/1556-4029.14894
   PubMed Web of Science ®Google Scholar
• Deloitte Access Economics. (2019). The social and economic costs of ADHD in Australia. Deloitte Access Economics. https://www2.deloitte.com/au/en/pages/economics/articles/social-economic-costs-adhd-Australia.html
   Google Scholar
• Dudgeon, P., Milroy, H., & Walker, H. (2014). Working together: Aboriginal and Torres Strait Islander mental health and wellbeing principles and practice (2nd ed.). Commonwealth of Australia.
   Google Scholar
• Edvinsson, D., Bingefors, K., Lindström, E., & Lewander, T. (2010). ADHD-related symptoms among adults in out-patient psychiatry and female prison inmates as compared with the general population. Upsala Journal of Medical Sciences, 115(1), 30–40. https://doi.org/10.3109/03009730903532333
   PubMed Web of Science ®Google Scholar
• Epstein, J., & Loren, R. (2013). Changes in the definition of ADHD in DSM-5: Subtle but important. Neuropsychiatry, 3(5), 455–458. https://doi.org/10.2217/npy.13.59
   PubMedGoogle Scholar
• Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., Newcorn, J. H., Gignac, M., Al Saud, N. M., Manor, I., Rohde, L. A., Yang, L., Cortese, S., Almagor, D., Stein, M. A., Albatti, T. H., Aljoudi, H. F., Alqahtani, M. M. J., Asherson, P., … Wang, Y. (2021). The World Federation of ADHD international consensus statement: 208 Evidence-based conclusions about the disorder. Neuroscience and Biobehavioral Reviews, 128, 789–818. https://doi.org/10.1016/j.neubiorev.2021.01.022
   PubMed Web of Science ®Google Scholar
• Faraone, S. V., Biederman, J., Spencer, T. J., & Aleardi, M. (2006). Comparing the efficacy of medications for ADHD using meta-analysis. Medscape General Medicine, 8(4), 4.
   PubMedGoogle Scholar
• Freckelton, I. (2019). Attention deficit hyperactivity disorder (ADHD) and the criminal law. Psychiatry, Psychology and Law, 26(6), 817–840. https://doi.org/10.1080/13218719.2019.1695266
   PubMed Web of Science ®Google Scholar
• Ghosh, M., Holman, C. D. J., & Preen, D. B. (2015). Use of prescription stimulant for attention deficit hyperactivity disorder in Aboriginal children and adolescents: A linked data cohort study. BMC Pharmacology & Toxicology, 16(1), 35. https://doi.org/10.1186/s40360-015-0035-8
   PubMedGoogle Scholar
• Ginsberg, Y., Hirvikoski, T., Grann, M., & Lindefors, N. (2012). Long-term functional outcome in adult prison inmates with ADHD receiving OROS-Methylphenidate. European Archives of Psychiatry and Clinical Neuroscience, 262(8), 705–724. https://doi.org/10.1007/s00406-012-0317-8
   PubMed Web of Science ®Google Scholar
• Ginsberg, Y., Hirvikoski, T., & Lindefors, N. (2010). Attention deficit hyperactivity disorder (ADHD) among longer-term prison inmates is a prevalent, persistent and disabling disorder. BMC Psychiatry, 10(1), 112. https://doi.org/10.1186/1471-244X-10-112
   PubMed Web of Science ®Google Scholar
• Ginsberg, Y., Långström, N., Larsson, H., & Lichtenstein, P. (2013). ADHD and criminality: Could treatment benefit prisoners with ADHD who are at higher risk of reoffending? Expert Review of Neurotherapeutics, 13(4), 345–348. https://doi.org/10.1586/ern.13.22
   PubMed Web of Science ®Google Scholar
• Ginsberg, Y., Långström, N., Larsson, H., & Lindefors, N. (2015). Long-term treatment outcome in adult male prisoners with attention-deficit/hyperactivity disorder: Three-year naturalistic follow-up of a 52-week methylphenidate trial. Journal of Clinical Psychopharmacology, 35(5), 535–543. https://doi.org/10.1097/JCP.0000000000000395
   PubMed Web of Science ®Google Scholar
• Ginsberg, Y., & Lindefors, N. (2012). Methylphenidate treatment of adult male prison inmates with attention-deficit hyperactivity disorder: Randomised double-blind placebo-controlled trial with open-label extension. The British Journal of Psychiatry, 200(1), 68–73. https://doi.org/10.1192/bjp.bp.111.092940
   PubMed Web of Science ®Google Scholar
• Hammerness, P., Petty, C., Faraone, S., & Biederman, J. (2017). Do stimulants reduce the risk for alcohol and substance use in youth with ADHD? A secondary analysis of a prospective, 24-month open-label study of osmotic-release methylphenidate. Journal of Attention Disorders, 21(1), 71–77. https://doi.org/10.1177/1087054712468051
   PubMed Web of Science ®Google Scholar
• Hunt, G. (2021, January 30). Greater access to life-changing medicine for Australians with ADHD. Department of Health and Aged Care. https://www.health.gov.au/ministers/the-hon-greg-hunt-mp/media/greater-access-to-life-changing-medicine-for-australians-with-adhd
   Google Scholar
• Kaye, S., Darke, S., & Torok, M. (2013). Attention deficit hyperactivity disorder (ADHD) among illicit psychostimulant users: A hidden disorder? Addiction, 108(5), 923–931. https://doi.org/10.1111/add.12086
   PubMed Web of Science ®Google Scholar
• Konstenius, M., Jayaram‐Lindström, N., Guterstam, J., Beck, O., Philips, B., & Franck, J. (2014). Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: A 24‐week randomized placebo‐controlled trial. Addiction, 109(3), 440–449. https://doi.org/10.1111/add.12369
   PubMed Web of Science ®Google Scholar
• Konstenius, M., Larsson, H., Lundholm, L., Philips, B., van de Glind, G., Jayaram-Lindström, N., & Franck, J. (2015). An epidemiological study of ADHD, substance use, and comorbid problems in incarcerated women in Sweden. Journal of Attention Disorders, 19(1), 44–52. https://doi.org/10.1177/1087054712451126
   PubMed Web of Science ®Google Scholar
• Kooij, J. J. S., Bijlenga, D., Salerno, L., Jaeschke, R., Bitter, I., Balázs, J., Thome, J., Dom, G., Kasper, S., Nunes Filipe, C., Stes, S., Mohr, P., Leppämäki, S., Casas, M., Bobes, J., Mccarthy, J. M., Richarte, V., Kjems Philipsen, A., Pehlivanidis, A., … Asherson, P. (2019). Updated European Consensus Statement on diagnosis and treatment of adult ADHD. European Psychiatry, 56(1), 14–34. https://doi.org/10.1016/j.eurpsy.2018.11.001
   PubMedGoogle Scholar
• Lane, C., & Chong, M. (2019). A hard pill to swallow: The need to identify and treat ADHD to reduce sufferers’ potential involvement in the criminal justice system. James Cook University Law Review, 25, 119–136. https://researchonline.jcu.edu.au/62329/
   Google Scholar
• Lichtenstein, P., Halldner, L., Zetterqvist, J., Sjölander, A., Serlachius, E., Fazel, S., Långström, N., & Larsson, H. (2012). Medication for attention deficit–hyperactivity disorder and criminality. The New England Journal of Medicine, 367(21), 2006–2014. https://doi.org/10.1056/NEJMoa1203241
   PubMed Web of Science ®Google Scholar
• Loh, P., Hayden, G., Vicary, D., Mancini, V., Martin, N., & Piek, J. (2016). Australian Aboriginal perspectives of attention deficit hyperactivity disorder. The Australian and New Zealand Journal of Psychiatry, 50(4), 309–310. https://doi.org/10.1177/0004867415624551
   PubMed Web of Science ®Google Scholar
• Loh, P., Hayden, G., Vicary, D., Mancini, V., Martin, N., & Piek, J. (2017). Attention deficit hyperactivity disorder: An Aboriginal perspective on diagnosis and intervention. Journal of Tropical Psychology, 7, e2. https://doi.org/10.1017/jtp.2017.1
   Google Scholar
• Lusardi, R. (2019). Current trends in medicalisation: Universalising ADHD diagnosis and treatments. Sociology Compass, 13(6), e12697. https://doi.org/10.1111/soc4.12697
   Web of Science ®Google Scholar
• Lynskey, M. T., & Hall, W. (2001). Attention deficit hyperactivity disorder and substance use disorders: Is there a causal link? Addiction, 96(6), 815–822. https://doi.org/10.1046/j.1360-0443.2001.9668153.x
   PubMed Web of Science ®Google Scholar
• Mattes, J. A. (2016). Treating ADHD in prison: Focus on alpha-2 agonists (clonidine and guanfacine). The Journal of the American Academy of Psychiatry and the Law, 44(2), 151–157. https://jaapl.org/content/44/2/151
   PubMed Web of Science ®Google Scholar
• Mohr-Jensen, C., & Steinhausen, H. (2016). A meta-analysis and systematic review of the risks associated with childhood attention-deficit hyperactivity disorder on long-term outcome of arrests, convictions, and incarcerations. Clinical Psychology Review, 48, 32–42. https://doi.org/10.1016/j.cpr.2016.05.002
   PubMed Web of Science ®Google Scholar
• Moore, E., Sunjic, S., Kaye, S., Archer, V., & Indig, D. (2016). Adult ADHD among NSW prisoners: Prevalence and psychiatric comorbidity. Journal of Attention Disorders, 20(11), 958–967. https://doi.org/10.1177/1087054713506263
   PubMed Web of Science ®Google Scholar
• Mordre, M., Groholt, B., Kjelsberg, E., Sandstad, B., & Myhre, A. (2011). The impact of ADHD and conduct disorder in childhood on adult delinquency: A 30 years follow-up study using official crime records. BMC Psychiatry, 11(1), 57. https://doi.org/10.1186/1471-244X-11-57
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Mental Health. (2009). Attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults. British Psychological Society. https://www.ncbi.nlm.nih.gov/books/NBK53652/
   Google Scholar
• National Disability Insurance Scheme Act 2013 (Cth).
   Google Scholar
• National Institute for Health and Care Excellence (NICE). (2018). Attention deficit hyperactivity disorder: Diagnosis and management (NICE Guideline 87). NICE. https://www.nice.org.uk/guidance/ng87/resources/attention-deficit-hyperactivity-disorder-diagnosis-and-management-pdf-1837699732933
   Google Scholar
• New South Wales (NSW) Government Health. (2018). ADHD – frequently asked questions. NSW Government Health. https://www.health.nsw.gov.au/pharmaceutical/patients/Pages/faq-adhd-consumers.aspx
   Google Scholar
• Prosser, B., Lambert, M., & Reid, R. (2015). Psychostimulant prescription for ADHD in New South Wales: A longitudinal perspective. Journal of Attention Disorders, 19(4), 284–292. https://doi.org/10.1177/1087054714553053
   PubMed Web of Science ®Google Scholar
• Rösler, M., Retz, W., Retz-Junginger, P., Hengesch, G., Schneider, M., Supprian, T., Schwitzgebel, P., Pinhard, K., Dovi–Akue, N., Wender, P., & Thome, J. (2004). Prevalence of attention deficit–/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates. European Archives of Psychiatry and Clinical Neuroscience, 254(6), 365–371. https://doi.org/10.1007/s00406-004-0516-z
   PubMed Web of Science ®Google Scholar
• Rösler, M., Retz, W., Yaqoobi, K., Burg, E., & Retz-Junginger, P. (2009). Attention deficit/hyperactivity disorder in female offenders: Prevalence, psychiatric comorbidity and psychosocial implications. European Archives of Psychiatry and Clinical Neuroscience, 259(2), 98–105. https://doi.org/10.1007/s00406-008-0841-8
   PubMed Web of Science ®Google Scholar
• Scott, D., Gignac, M., Kronfli, R., Ocana, A., & Lorberg, G. (2016). Expert opinion and recommendations for the management of attention-deficit/hyperactivity disorder in correctional facilities. Journal of Correctional Health Care, 22(1), 46–61. https://doi.org/10.1177/1078345815618392
   PubMed Web of Science ®Google Scholar
• United Nations (UN). (2015). Standard minimum rules for the treatment of prisoners (the Nelson Mandela Rules). UN. https://www.ohchr.org/Documents/ProfessionalInterest/NelsonMandelaRules.pdf
   Google Scholar
• World Health Organization (WHO). (2019). International statistical classification of diseases and related health problems (11th ed.). WHO.
   Google Scholar
• Young, J. T., van Dooren, K., Borschmann, R., & Kinner, S. A. (2017). ACT Detainee Health and Wellbeing Survey 2016: Summary results. ACT Government. https://www.ics.act.gov.au/__data/assets/pdf_file/0009/1325997/2016-ACT-Detainee-Health-and-Wellbeing-Survey-Report.pdf
   Google Scholar
• Young, S., Adamo, N., Ásgeirsdóttir, B. B., Branney, P., Beckett, M., Colley, W., Cubbin, S., Deeley, Q., Farrag, E., Gudjonsson, G., Hill, P., Hollingdale, J., Kilic, O., Lloyd, T., Mason, P., Paliokosta, E., Perecherla, S., Sedgwick, J., Skirrow, C., … Woodhouse, E. (2020). Females with ADHD: An expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit/hyperactivity disorder in girls and women. BMC Psychiatry, 20(1), 404. https://doi.org/10.1186/s12888-020-02707-9
   PubMed Web of Science ®Google Scholar
• Young, S., Adamou, M., Bolea, B., Gudjonsson, G., Müller, U., Pitts, M., Thome, J., & Asherson, P. (2011). The identification and management of ADHD offenders within the criminal justice system: A consensus statement from the UK Adult ADHD Network and criminal justice agencies. BMC Psychiatry, 11(1), 32. https://doi.org/10.1186/1471-244X-11-32
   PubMedGoogle Scholar
• Young, S., & Cocallis, K. (2021). ADHD and offending. Journal of Neural Transmission, 128(7), 1009–1019. https://doi.org/10.1007/s00702-021-02308-0
   PubMed Web of Science ®Google Scholar
• Young, S., González, R. A., Fridman, M., Hodgkins, P., Kim, K., & Gudjonsson, G. H. (2018). The economic consequences of attention-deficit hyperactivity disorder in the Scottish prison system. BMC Psychiatry, 18(1), 210. https://doi.org/10.1186/s12888-018-1792-x
   PubMedGoogle Scholar
• Young, S., González, R. A., Wolff, K., Xenitidis, K., Mutch, L., Malet-Lambert, I., & Gudjonsson, G. H. (2020). Substance and alcohol misuse, drug pathways, and offending behaviors in association with ADHD in prison inmates. Journal of Attention Disorders, 24(13), 1905–1913. https://doi.org/10.1177/1087054716688532
   PubMed Web of Science ®Google Scholar
• Young, S., Goodwin, E. J., Sedgwick, O., & Gudjonsson, G. H. (2013). The effectiveness of police custody assessments in identifying suspects with intellectual disabilities and attention deficit hyperactivity disorder. BMC Medicine, 11(1), 248. https://doi.org/10.1186/1741-7015-11-248
   PubMed Web of Science ®Google Scholar
• Young, S., Gudjonsson, G., Chitsabesan, P., Colley, B., Farrag, E., Forrester, A., Hollingdale, J., Kim, K., Lewis, A., Maginn, S., Mason, P., Ryan, S., Smith, J., Woodhouse, E., & Asherson, P. (2018). Identification and treatment of offenders with attention-deficit/hyperactivity disorder in the prison population: A practical approach based upon expert consensus. BMC Psychiatry, 18(1), 281. https://doi.org/10.1186/s12888-018-1858-9
   PubMedGoogle Scholar
• Young, S., Moss, D., Sedgwick, O., Fridman, M., & Hodgkins, P. (2015). A meta-analysis of the prevalence of attention deficit hyperactivity disorder in incarcerated populations. Psychological Medicine, 45(2), 247–258. https://doi.org/10.1017/S0033291714000762
   PubMed Web of Science ®Google Scholar
• Young, S., Sedgwick, O., Fridman, M., Gudjonsson, G., Hodgkins, P., Lantigua, M., & González, R. A. (2015). Co-morbid psychiatric disorders among incarcerated ADHD populations: A meta-analysis. Psychological Medicine, 45(12), 2499–2510. https://doi.org/10.1017/S0033291715000598
   PubMed Web of Science ®Google Scholar
• Young, S., Wells, J., & Gudjonsson, G. H. (2011). Predictors of offending among prisoners: The role of attention-deficit hyperactivity disorder and substance use. Journal of Psychopharmacology, 25(11), 1524–1532. https://doi.org/10.1177/0269881110370502
   PubMed Web of Science ®Google Scholar